Futibatinib Uses, Dosage, Side Effects and more
Futibatinib is under investigation in clinical trial NCT02052778 (A Study of TAS-120 in Patients With Advanced Solid Tumors).
| Trade Name | Futibatinib |
| Generic | Futibatinib |
| Futibatinib Other Names | Futibatinib |
| Type | |
| Formula | C22H22N6O3 |
| Weight | Average: 418.457 Monoisotopic: 418.175338592 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
